Takeda Pharmaceutical Company Limited Recognised Assets Defined Benefit Plan
Takeda Pharmaceutical Company Limited (TKPHF) had Recognised Assets Defined Benefit Plan of JPY 19.35 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:RecognisedAssetsDefinedBenefitPlan · last filed 2025-06-25
- 2025-03-31: Recognised Assets Defined Benefit Plan 19.35B JPY.
- 2024-03-31: Recognised Assets Defined Benefit Plan 27.41B JPY.
- 2023-03-31: Recognised Assets Defined Benefit Plan 30.82B JPY.
- 2022-03-31: Recognised Assets Defined Benefit Plan 34.48B JPY.
| Period end | Recognised Assets Defined Benefit Plan |
|---|---|
| 2025-03-31 | 19.35B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 27.41B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 30.82B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 34.48B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 34.40B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 30.38B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 34.44B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 41.38B JPY 20-F · filed 2019-06-27 |